Archive: 11/02/2014
Mallinckrodt buying Cadence Pharma for $1.21B
Health care products company Mallinckrodt is buying Cadence Pharmaceuticals Inc. for about $1.21 billion to help enhance its specialty pharmaceuticals segment.
Feb 11, 2014
Internists review progress, challenges and opportunities
"For the first time in the history of the United States, Americans are experiencing the benefits of health reforms designed to ensure that everyone has access to affordable coverage including a suite of essential benefits," ...
Feb 11, 2014
Researchers use antibody treatment to protect humanized mice from HIV
NIH-funded scientists have shown that boosting the production of certain broadly neutralizing antibodies can protect humanized mice from both intravenous and vaginal infection with HIV. Humanized mice have immune systems ...
Feb 11, 2014
I smoke, but I'm not a smoker: Why some 'non-identifying smokers' face risks while denying the behavior
While smoking among California adults has dramatically declined in recent decades, researchers at the University of California, San Diego School of Medicine report there is a surprisingly large number of people who say they ...
Feb 11, 2014
Child abuse rises with income inequality, study shows
As the Great Recession deepened and income inequality became more pronounced, county-by-county rates of child maltreatment – from sexual, physical and emotional abuse to traumatic brain injuries and death – worsened, ...
Feb 11, 2014